Ventyx Biosciences Inc. (VTYX)
1.95
0.01 (0.52%)
At close: Jan 15, 2025, 3:59 PM
1.96
0.51%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -192.96M | -108.43M | -83.75M | -28.17M | -4.33M |
| Depreciation & Amortization | 941.00K | 470.00K | 30.00K | n/a | n/a |
| Stock-Based Compensation | 28.59M | 16.57M | 2.73M | 45.00K | 198.00K |
| Other Working Capital | 6.55M | -6.77M | 1.57M | 221.00K | 230.00K |
| Other Non-Cash Items | -8.89M | -2.23M | 38.32M | 21.12M | 896.00K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 5.81M | -5.16M | 4.02M | 812.00K | 591.00K |
| Operating Cash Flow | -166.52M | -98.77M | -38.65M | -6.20M | -2.64M |
| Capital Expenditures | -514.00K | -275.00K | -262.00K | n/a | n/a |
| Acquisitions | n/a | 74.66K | 1.90M | n/a | n/a |
| Purchase of Investments | -272.27M | -347.24M | -232.50M | n/a | n/a |
| Sales Maturities Of Investments | 373.73M | 272.58M | 16.50M | n/a | n/a |
| Other Investing Acitivies | n/a | -74.66K | -216.00K | n/a | n/a |
| Investing Cash Flow | 100.94M | -74.93M | -214.37M | n/a | n/a |
| Debt Repayment | n/a | n/a | 450.00K | 6.13M | 2.95M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 4.92M | 2.37M | 164.29M | 2.00K | 1K |
| Financial Cash Flow | 53.33M | 167.77M | 323.55M | 6.13M | 2.95M |
| Net Cash Flow | -12.27M | -5.97M | 70.55M | -65.00K | 309.00K |
| Free Cash Flow | -167.04M | -99.05M | -38.91M | -6.20M | -2.64M |